Fisher Investments denies WSJ report that it's in sale talks
By Mike Murphy
Money-management firm Fisher Investments late Tuesday denied a report that it's in sale talks with private-equity firm Advent International.
The Wall Street Journal, citing sources familiar with the matter, reported Tuesday that acquisition talks were underway. No further details were revealed, and the Journal reported that it's possible no deal will be made, or that other suitors for Fisher's firm will emerge.
That report was vehemently denied.
"Fisher Investments is not being bought by Advent International, or anyone else - plain and simple. Had the Wall Street Journal bothered to verify their story with us before going to print, we would have corrected them," Naj Srinivas, Fisher's executive vice president for corporate communications, said in an email.
Advent also denied the report. "Advent is not buying Fisher Investments," a spokesperson said.
Billionaire Ken Fisher founded Fisher Investments in 1979. It manages about $236 billion in assets worldwide, according to its website. Fisher moved from CEO to executive chairman and co-chief investment officer in 2016.
Clients withdrew millions from Fisher's fund in 2019, after he made lewd comments during an interview at a financial-industry conference. Fisher later apologized for his remarks.
Last year, he moved his firm's headquarters from Washington state to Texas, citing Washington's high capital-gains tax.
Advent focuses on buyouts, with $92 billion in assets under management, according to its website. In November, Advent named Tricia Rothschild as an operating partner, and said she would play "a key role" in finding new investments in wealth and asset management.
-Mike Murphy
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
01-02-24 2140ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks